Bupropion SR for relapse prevention: A "slips-allowed" analysis

Michael J. Durcan, J. Andrew Johnston, Jonathan White, David Gonzales, David P.L. Sachs, Nancy Rigotti, Raymond Niaura

Research output: Contribution to journalArticle

Abstract

Objective: To assess the efficacy of bupropion SR on smoking abstinence using a "slips allowed" analysis. Methods: Retrospective analysis, which did not consider brief episodic "slips" as a return to regular smoking, of data from a multicenter, randomized, double- blind, placebo-controlled relapse prevention study. Results: Using a slips-allowed analysis, median time to relapse on bupropion SR was 65 weeks versus 30 weeks on placebo. This is compared to 32 and 20 weeks, respectively, using a traditional analysis not allowing for slips. Conclusion: Bupropion SR is efficacious for the prevention of smoking relapse. A slips-allowed analysis may provide a more clinically relevant assessment of efficacy.

Original languageEnglish (US)
Pages (from-to)456-463
Number of pages8
JournalAmerican Journal of Health Behavior
Volume28
Issue number5
StatePublished - Sep 2004

Fingerprint

Bupropion
relapse
Secondary Prevention
Smoking
smoking
Placebos
Recurrence

Keywords

  • Bupropion
  • Relapse prevention
  • Slips allowed analysis
  • Smoking cessation

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health

Cite this

Durcan, M. J., Johnston, J. A., White, J., Gonzales, D., Sachs, D. P. L., Rigotti, N., & Niaura, R. (2004). Bupropion SR for relapse prevention: A "slips-allowed" analysis. American Journal of Health Behavior, 28(5), 456-463.

Bupropion SR for relapse prevention : A "slips-allowed" analysis. / Durcan, Michael J.; Johnston, J. Andrew; White, Jonathan; Gonzales, David; Sachs, David P.L.; Rigotti, Nancy; Niaura, Raymond.

In: American Journal of Health Behavior, Vol. 28, No. 5, 09.2004, p. 456-463.

Research output: Contribution to journalArticle

Durcan, MJ, Johnston, JA, White, J, Gonzales, D, Sachs, DPL, Rigotti, N & Niaura, R 2004, 'Bupropion SR for relapse prevention: A "slips-allowed" analysis', American Journal of Health Behavior, vol. 28, no. 5, pp. 456-463.
Durcan MJ, Johnston JA, White J, Gonzales D, Sachs DPL, Rigotti N et al. Bupropion SR for relapse prevention: A "slips-allowed" analysis. American Journal of Health Behavior. 2004 Sep;28(5):456-463.
Durcan, Michael J. ; Johnston, J. Andrew ; White, Jonathan ; Gonzales, David ; Sachs, David P.L. ; Rigotti, Nancy ; Niaura, Raymond. / Bupropion SR for relapse prevention : A "slips-allowed" analysis. In: American Journal of Health Behavior. 2004 ; Vol. 28, No. 5. pp. 456-463.
@article{7d1c1b8863ec4c09836287c0d1f551bd,
title = "Bupropion SR for relapse prevention: A {"}slips-allowed{"} analysis",
abstract = "Objective: To assess the efficacy of bupropion SR on smoking abstinence using a {"}slips allowed{"} analysis. Methods: Retrospective analysis, which did not consider brief episodic {"}slips{"} as a return to regular smoking, of data from a multicenter, randomized, double- blind, placebo-controlled relapse prevention study. Results: Using a slips-allowed analysis, median time to relapse on bupropion SR was 65 weeks versus 30 weeks on placebo. This is compared to 32 and 20 weeks, respectively, using a traditional analysis not allowing for slips. Conclusion: Bupropion SR is efficacious for the prevention of smoking relapse. A slips-allowed analysis may provide a more clinically relevant assessment of efficacy.",
keywords = "Bupropion, Relapse prevention, Slips allowed analysis, Smoking cessation",
author = "Durcan, {Michael J.} and Johnston, {J. Andrew} and Jonathan White and David Gonzales and Sachs, {David P.L.} and Nancy Rigotti and Raymond Niaura",
year = "2004",
month = "9",
language = "English (US)",
volume = "28",
pages = "456--463",
journal = "American Journal of Health Behavior",
issn = "1087-3244",
publisher = "PNG Publications",
number = "5",

}

TY - JOUR

T1 - Bupropion SR for relapse prevention

T2 - A "slips-allowed" analysis

AU - Durcan, Michael J.

AU - Johnston, J. Andrew

AU - White, Jonathan

AU - Gonzales, David

AU - Sachs, David P.L.

AU - Rigotti, Nancy

AU - Niaura, Raymond

PY - 2004/9

Y1 - 2004/9

N2 - Objective: To assess the efficacy of bupropion SR on smoking abstinence using a "slips allowed" analysis. Methods: Retrospective analysis, which did not consider brief episodic "slips" as a return to regular smoking, of data from a multicenter, randomized, double- blind, placebo-controlled relapse prevention study. Results: Using a slips-allowed analysis, median time to relapse on bupropion SR was 65 weeks versus 30 weeks on placebo. This is compared to 32 and 20 weeks, respectively, using a traditional analysis not allowing for slips. Conclusion: Bupropion SR is efficacious for the prevention of smoking relapse. A slips-allowed analysis may provide a more clinically relevant assessment of efficacy.

AB - Objective: To assess the efficacy of bupropion SR on smoking abstinence using a "slips allowed" analysis. Methods: Retrospective analysis, which did not consider brief episodic "slips" as a return to regular smoking, of data from a multicenter, randomized, double- blind, placebo-controlled relapse prevention study. Results: Using a slips-allowed analysis, median time to relapse on bupropion SR was 65 weeks versus 30 weeks on placebo. This is compared to 32 and 20 weeks, respectively, using a traditional analysis not allowing for slips. Conclusion: Bupropion SR is efficacious for the prevention of smoking relapse. A slips-allowed analysis may provide a more clinically relevant assessment of efficacy.

KW - Bupropion

KW - Relapse prevention

KW - Slips allowed analysis

KW - Smoking cessation

UR - http://www.scopus.com/inward/record.url?scp=13244262595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244262595&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 456

EP - 463

JO - American Journal of Health Behavior

JF - American Journal of Health Behavior

SN - 1087-3244

IS - 5

ER -